Earnings Per Common Share Attributable to Common Shareholders

6 Months Ended

Jun. 28, 2015

Earnings Per Common Share Attributable to Common Shareholders



The following table provides the detailed calculation of Earnings per common share (EPS):
	Three Months Ended				Six Months Ended
(IN MILLIONS)	June 28, 2015		June 29, 2014		June 28, 2015		June 29, 2014
EPS Numerator––Basic
Income from continuing operations	$	2,635	$	2,921	$	5,011	$	5,186
Less: Net income attributable to noncontrolling interests	9		9		14		18
Income from continuing operations attributable to Pfizer Inc.	2,626		2,912		4,996		5,168
Less: Preferred stock dividends––net of tax	—		1		1		1
Income from continuing operations attributable to Pfizer Inc. common shareholders	2,625		2,911		4,996		5,167
Discontinued operations––net of tax	1		—		6		73
Less: Discontinued operations––net of tax, attributable to noncontrolling interests	—		—		—		—
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders	1		—		6		73
Net income attributable to Pfizer Inc. common shareholders	$	2,626	$	2,911	$	5,002	$	5,240
EPS Numerator––Diluted
Income from continuing operations attributable to Pfizer Inc. common shareholders and assumed conversions	$	2,626	$	2,912	$	4,996	$	5,168
Discontinued operations––net of tax, attributable to Pfizer Inc. common shareholders and assumed conversions	1		—		6		73
Net income attributable to Pfizer Inc. common shareholders and assumed conversions	$	2,626	$	2,912	$	5,002	$	5,241
EPS Denominator
Weighted-average number of common shares outstanding––Basic	6,159		6,368		6,181		6,379
Common-share equivalents: stock options, stock issuable under employee compensation plans, convertible preferred stock and accelerated share repurchase agreement	83		76		86		81
Weighted-average number of common shares outstanding––Diluted	6,243		6,444		6,267		6,460
Stock options that had exercise prices greater than the average market price of our common stock issuable under employee compensation plans^(a)	56		44		45		44


^(a)	These common stock equivalents were outstanding for the six months ended June 28, 2015 and June 29, 2014, but were not included in the computation of diluted EPS for those periods because their inclusion would have had an anti-dilutive effect.